Cargando…
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis
BACKGROUND: Infections are a common cause of morbidity and mortality in patients with acute myeloid leukemia (AML). The evidence for efficacy of antibiotic prophylaxis in reducing the mortality rates and the incidence of bacterial infections was also reported by a systematic review published by Coch...
Autores principales: | De Rosa, Francesco Giuseppe, Motta, Ilaria, Audisio, Ernesta, Frairia, Chiara, Busca, Alessandro, Di Perri, Giovanni, Marmont, Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219399/ https://www.ncbi.nlm.nih.gov/pubmed/24289496 http://dx.doi.org/10.1186/1471-2334-13-563 |
Ejemplares similares
-
Levofloxacin Prophylaxis Versus no Prophylaxis in Acute Myeloid Leukemia During Post-Induction Aplasia: a Single Center Study
por: Urbino, Irene, et al.
Publicado: (2023) -
Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021
por: Urbino, Irene, et al.
Publicado: (2021) -
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors
por: Boscaro, Eleonora, et al.
Publicado: (2023) -
Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy
por: Ziegler, Matthew, et al.
Publicado: (2019) -
194. Antibiotic-resistant bloodstream infections in pediatric oncology patients on levofloxacin prophylaxis
por: Sridhar, Sunita, et al.
Publicado: (2020)